Relit Biosciences
Relit Biosciences gives patients access to biomarker-based imaging and radioligand therapy, the pairing of a diagnostic scan with a matched radioactive drug.
Overview
Relit Biosciences describes itself as a patient's access point to biomarker-based imaging and radiotherapeutics: theranostic scans that show whether a tumour carries a target such as PSMA or somatostatin receptors, and the radioligand therapies that follow. It is an Even One Ventures portfolio company; its public site is a single page with a contact address.
Funding
All startupsSimilar pages
not linked directly; found by shared links- CompanyEcho Immune
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyRanata Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyYuga Bio
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyInvocata
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyMinuteman Therapeutics
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyValius Sciences
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyKernis Health
Shares Even One Ventures and the tags startup, evenone-portfolio, oncology.
- CompanyArden Bio
Shares Even One Ventures and the tags startup, evenone-portfolio.